Management commentary

Joseph F. Goldberg

doi:10.1017/CBO9781139003315.026

Management commentary

Joseph F. Goldberg

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Optimal management for patients with BP II involves tailored, individualised treatment that is informed, but not dictated, by the clinical trials literature. It is precisely because of controversy and uncertainty about the nosology of BP II, and its differential diagnosis, that a systematic and thorough assessment of clinical features rightfully precedes treatment, in order to avoid premature diagnostic or therapeutic conclusions. Implementing reasonable and appropriate treatments, with clear rationales, can only occur after the careful evaluation of symptoms and clinical context in light of past history.

Original language	English
Title of host publication	Bipolar II Disorder
Subtitle of host publication	Modelling, Measuring and Managing, Second Edition
Publisher	Cambridge University Press
Pages	237-240
Number of pages	4
ISBN (Electronic)	9781139003315
ISBN (Print)	9781107600898
DOIs	https://doi.org/10.1017/CBO9781139003315.026
State	Published - 1 Jan 2012
Externally published	Yes

Access to Document

10.1017/CBO9781139003315.026

Cite this

@inbook{edfc279cb7ad402e9a0002f2ee6e119a,

title = "Management commentary",

abstract = "Optimal management for patients with BP II involves tailored, individualised treatment that is informed, but not dictated, by the clinical trials literature. It is precisely because of controversy and uncertainty about the nosology of BP II, and its differential diagnosis, that a systematic and thorough assessment of clinical features rightfully precedes treatment, in order to avoid premature diagnostic or therapeutic conclusions. Implementing reasonable and appropriate treatments, with clear rationales, can only occur after the careful evaluation of symptoms and clinical context in light of past history.",

author = "Goldberg, {Joseph F.}",

note = "Publisher Copyright: {\textcopyright} Cambridge University Press 2012.",

year = "2012",

month = jan,

day = "1",

doi = "10.1017/CBO9781139003315.026",

language = "English",

isbn = "9781107600898",

pages = "237--240",

booktitle = "Bipolar II Disorder",

publisher = "Cambridge University Press",

address = "United Kingdom",

}

TY - CHAP

T1 - Management commentary

AU - Goldberg, Joseph F.

N1 - Publisher Copyright: © Cambridge University Press 2012.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Optimal management for patients with BP II involves tailored, individualised treatment that is informed, but not dictated, by the clinical trials literature. It is precisely because of controversy and uncertainty about the nosology of BP II, and its differential diagnosis, that a systematic and thorough assessment of clinical features rightfully precedes treatment, in order to avoid premature diagnostic or therapeutic conclusions. Implementing reasonable and appropriate treatments, with clear rationales, can only occur after the careful evaluation of symptoms and clinical context in light of past history.

AB - Optimal management for patients with BP II involves tailored, individualised treatment that is informed, but not dictated, by the clinical trials literature. It is precisely because of controversy and uncertainty about the nosology of BP II, and its differential diagnosis, that a systematic and thorough assessment of clinical features rightfully precedes treatment, in order to avoid premature diagnostic or therapeutic conclusions. Implementing reasonable and appropriate treatments, with clear rationales, can only occur after the careful evaluation of symptoms and clinical context in light of past history.

UR - http://www.scopus.com/inward/record.url?scp=84925674877&partnerID=8YFLogxK

U2 - 10.1017/CBO9781139003315.026

DO - 10.1017/CBO9781139003315.026

M3 - Chapter

AN - SCOPUS:84925674877

SN - 9781107600898

SP - 237

EP - 240

BT - Bipolar II Disorder

PB - Cambridge University Press

ER -

Management commentary

Abstract

Access to Document

Fingerprint

Cite this